January 6, 2015 / 9:59 PM / in 3 years

BUZZ-KaloBios Pharmaceuticals Inc: Stops lung drug development

** Drug developer’s shares down 60 pct at $0.74 after the bell

** Company drops experimental drug for lung infections after it failed mid-stage trial in cystic fibrosis patients

** Says drug, KB001-A, failed main goal of buying patients more time before taking antibiotics for worsening respiratory tract symptoms

** Up to Monday’s close, stock had lost 44.4 pct since Jan. 30, 2014 when company stopped developing asthma drug

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below